There is a correlation between HCC and a loss of LSEC markers including stabilin-1, stabilin-2, LYVE-1 and CD32b, whilst increasing expression of integrins and ICAM-1 and capacity for angiogenesis, coagulation and fibrinolysis (Wu et al., 2008). Here, ICAM1 is linked to hepatocellular carcinoma.